Syngenta Chief Executive Officer Erik Fyrwald sees the imminent $43 billion Chinese takeover of the Swiss company as a timely moment to gain a powerful benefactor just as a host of antitrust reviews trigger an abundance of acquisition opportunities.
The next few years will see billions of dollars in acquisition opportunities, and Fyrwald said he’s interested in looking at assets that could come to market as part of a tie-up between Bayer and Monsanto, as this opportunity won’t come around again.
“The majors will have consolidated, so I think in the future there’ll be more bolt-on-type deals of smaller companies that fill gaps where there are fewer overlaps and competitive concerns,” Fyrwald said in an interview in Brussels on Monday. China National Chemical is in the final stages of acquiring Syngenta.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
